HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eliot Parascandolo Selected Research

Rivaroxaban

9/2020Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eliot Parascandolo Research Topics

Disease

2Migraine Disorders (Migraine)
01/2022 - 06/2021
1Headache (Headaches)
06/2021
1Pain (Aches)
06/2021
1Trigeminal Neuralgia (Tic Douloureux)
06/2021
1Hemorrhage
09/2020

Drug/Important Bio-Agent (IBA)

1erenumabIBA
06/2021
1Monoclonal AntibodiesIBA
06/2021
1Calcitonin Gene-Related PeptideIBA
06/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2020
1RivaroxabanIBA
09/2020
1Factor Xa InhibitorsIBA
09/2020

Therapy/Procedure

1Length of Stay
01/2022
1Therapeutics
06/2021